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Background: Emulsifiers have a significant role in the emulsion polymerization by reducing the interfacial tension
thus increasing the stability of colloidal dispersions of polymer nanostructures. This study evaluates the impact of
four emulsifiers on the characteristics of polyurethane hollow structures used as drug delivery system.
Results: Polyurethane (PU) structures with high stability and sizes ranging from nano- to micro-scale were obtained
by interfacial polyaddition combined with spontaneous emulsification. The pH of PU aqueous solutions (0.1% w/w)
was slightly acidic, which is acceptable for products intended to be used on human skin. Agglomerated structures
with irregular shapes were observed by scanning electron microscopy. The synthesized structures have melting
points between 245-265°C and reveal promising results in different evaluations (TEWL, mexametry) on murine skin.
Conclusions: In this study hollow PU structures of reduced noxiousness were synthesized, their size and stability
being influenced by emulsifiers. Such structures could be used in the pharmaceutical field as future drug delivery
systems.
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Several varieties of structures (polymeric and metal
nano- and micro-particles, liposomes, micelles, quantum
dots, dendrimers, lipoproteins, nanotubs) were used as
drug carriers in order to reduce drug metabolism, drug
toxicity and to prolong in vivo drug activity [1]. The liver
isoenzymes known as cytochrome P450 are involved in
phase I of drug metabolism [2]. During a study of drug
elimination pathways it was established that the cyto-
chrome P450 is responsible for complete removal from the
human body of more than a half of 400 drugs marketed in
Europe and US [3]. Toxicity studies for polymer-
methotrexate conjugate vs. free methotrexate on murine
rheumatoid arthritis model indicate that the free compound
starts to cause animals’death at the maximum tolerated
dose and is highly toxic at LD50 level, while the polymer-
methotrexate conjugate shows no toxicity at the same
equivalent concentrations [4]. The drug carriers can pro-
long the in vivo drug activity, both by their controlled drug-* Correspondence: ionescu.daniela@umft.ro; fborcan@umft.ro
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distribution, and reproduction in any mediumrelease technology and a long-lasting target binding and
rebinding mechanism [5].
Polyurethanes are commonly used in medical applica-
tions and their use continues to expand due to their versa-
tility, biocompatibility and hemocompatibility. There are
several types of PU, including the following: liquid PU for
hollow-fiber devices, PU for dip-molding, PU coatings,
biostable PU and thermoplastic PU [6]. Sivak WN [7]
synthesized a novel PU drug delivery system based on ly-
sine diisocyanate and glycerol using various tertiary
amines and organometallic urethane as catalysts. The use
of LDI-glycerol PU foams as drug carriers for the con-
trolled release of 7-tert-butyldimethylsilyl-10-hydroxy-
camptothecin (DB-67) revealed that such foams were
capable of delivering therapeutic concentrations of DB-67
in vitro over an 11 weeks trial period [8].
The purpose of the present investigation was to develop
aliphatic PU structures with a diameter in the range of
100-300 nm in the absence of a catalyst. We also studied
the effect of four emulsifiers on the structures’ size and
stability and also their noxiousness on murine skin model.tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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The development of novel targeted nano-polymers in the
drug delivery field is currently a research topic of high
interest [9,10]. In our research the main aim was to avoid
the potentially toxic additional raw materials. Only aliphatic
compounds were used even if it is well-known that these
compounds lead to final products of poor physical and
mechanical properties [11]. In this synthesis the presence of
a chains’ initiator was not necessary and the reaction went
without catalyst. Unlike previous studies [12] a single
surfactant has been used instead of a mixture (lipophilic or
hydrophilic) and only in a small amount.
The pH values of PU solutions were determined using a
Schott TitroLine at 25°C as described in the literature [13].
The measurements were made in triplicate and data were
expressed as mean and standard deviation. The obtained
samples show slightly acidic pH values (5.88±0.11 for sam-
ple PuS-1, 6.07±0.09 for sample PuS-2, 5.98±0.16 for
PuS-3 and 6.24±0.09 for sample PuS-4). The above pH
values are appropriate for products intended for skin appli-
cation considering that skin pH is around 5.80 for men and
around 5.54 for women [14]. Variable skin pH values were
reported in the literature, all in the acidic domain, but vary-
ing from 4.0 to 7.0 depending on the purpose of using [15].
These slightly acidic solutions are acceptable for dermal
applications because they do not cause dry skin as a regular
soap does and also maintain the normal skin microflora.
The results obtained by using Zetasizer Nano ZS indi-
cate that PU structures are relatively homogeneous and
their size ranges from nano- to micro-scale (Table 1). The
increase of the emulsifier amount would most probably
reduce the structures’ size below 100 nm (the limit
between the two scales) because emulsifiers produce lower
interfacial tension and increase the stability of colloidal
dispersions, therefore avoiding aggregates’ formation.
Zeta potential values are used to predict particles’ stabil-
ity, stable particles presenting a zeta potential more
negative than -30 mV or more positive than +30 mV [16].
All this considered, the PU structures obtained in the first
two experiments (using Cremophor EL and Cremophor A6
as emulsifiers) are considered the most stable products.
The presence of macromolecular aggregates with irregu-
lar shapes was noticed using scanning electron micros-
copy (SEM). Irregular amorphous-crystalline nature of the





PuS-1 Cremophor EL 164 ± 12
PuS-2 Cremophor A6 201 ± 19
PuS-3 Cremophor A25 298 ± 11
PuS-4 Cremophor RH40 379 ± 233, 4). The non-spherical shape of the PU structures affect
their flowing properties and might also influence their
targeting ability [17]. SEM pictures revealed a non-porous
material which represents an advantage for a drug carrier
in terms of protection of its load. Non-agglomerated
structures cannot be successfully synthesized probably
due to the small amount of emulsifier which affects the
structures’ stability and tendency to pack [18].
At the glass transition temperature, Tg, the molecules
have enough energy to partially overcome the intermo-
lecular forces, and have more freedom of movement [19].
The presence of the PU structures glass transition is
noticed on the DSC curves around 65°C, which reveals
the predominant crystalline nature of the polymer [20]. A
crystallization exothermic peak (+124.5 mJ) was recorded
at 193.74°C in the case of PuS-4 sample. Further heating
above the crystallization temperature results in an endo-
thermic peak which corresponds to the melting of the crys-
talline region [21]. The melting points of the synthesized
PU structures were between 245-265°C (Figures 5, 6).
The thermal behaviour survey of the obtained PU struc-
tures has revealed that Cremophor-type emulsifiers did not
significantly influence the melting process.
TEWL was measured using a non-invasive procedure in
order to detect any skin barrier disorder. In the first day of
the experiment, all mice exhibited TEWL values between
0-10 g/h/m2, which is the specific range for a healthy skin,
values that were used as reference [22]. No significant
differences were noticed between animal groups or
between the first and last day of the experiment (Figure 7).
The best results were obtained in case of the mice treated
with PuS-1 and PuS-2 creams (TEWL differences below
3 g/h/m2 in 30 days, values which were also recorded in
the case of blank cream application).
Found in the basal layer of the epidermis, melanocytes
produce melanin which determines skin colour [23]. Stud-
ies concerning the melanin content of nude mice skin
were developed in order to establish the human malignant
melanomas’ progress [24], radioimmunotherapy efficacy
against experimental human metastatic melanoma [25] or
the effect of skin pigmentation in bioluminescent imaging
[26]. It is well-known that skin often reacts to external
agents by modifying the constitutive pigmentation pattern
[27]. In this study, the melanin content was investigated
using mice skin, which presents extremely close valueser Nano ZS
Particle size (nm) Zeta potential
(mV) mean ± SDPolydispersity index
0.2 33.9 ± 5.0
0.5 37.5 ± 4.4
0.4 23.0 ± 4.8
0.3 29.7 ± 3.1
Figure 1 SEM image of PuS-1 sample. Figure 3 SEM image of PuS-3 sample.
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the first day of the experiment). The melanin evolution
(Figure 8) presents an increase for all mice (whether they
were treated with blank cream or cream with PU struc-
tures); it is pertinent to mention that in the case of mice
treated with PuS-1 and PuS-2 creams the increase of
melanin content was not so pronounced.
Erythema (redness of the skin) caused by expansion and
congestion of the capillaries is usually a sign of inflamma-
tion or infection [28]. Irritant compounds such as surfac-
tants have been extensively studied in the last decade and it
has been noticed that erythema values can be correlated
with their irritation potential [29]. In this experiment, the
lowest change of the erythema (local haemoglobin) values
was noticed in case of the mice treated with blank cream
and PuS-2 cream respectively, which recommends the
latter as the transdermal carrier with the lowest toxicity
(Figure 9).Figure 2 SEM image of PuS-2 sample.Conclusions
In this research PU structures were synthesized using
a well-known procedure, the interfacial polyaddition
combined with spontaneous emulsification. HMDI in
acetone was used as isocyanate component and a
mixture of MEG, 1,4-BD and PEG 200 in water was
used as hydroxylic component. Four different emulsi-
fiers were used and the synthesis was done without
any chain initiator or catalyst. The PU structures
showed a good stability, melting points between 245-
265°C, and sizes between 150-400 nm. The PU struc-
tures were embedded in a cream for topical applica-
tions on murine skin. Evolution of TEWL, melanin
content and skin erythema were recorded for a period
of 30 days. The comparative analysis revealed that PU
structures based on Cremophor A6 present the best
toxicological profile and can be used as drug carriers
for therapeutic purposes.Figure 4 SEM image of PuS-4 sample.
Figure 5 DSC of PuS-1 sample (black) and PuS-2 sample (red).
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Raw materials
Hexamethylene diisocyanate (HMDI), polyethylene gly-
col (PEG 200) and acetone were obtained from Merck
(Germany). Emulsifiers (Cremophor EL, Cremophor
A6, Cremophor A25, and Cremophor RH40) wereFigure 6 DSC of PuS-3 sample (black) and PuS-4 sample (red).kindly donated by our colleagues from University of
Szeged (Hungary). Mono-ethylene glycol (MEG) was
purchased from Lach-Ner s.r.o. (Czech Rep.) while
1,4-butanediol (1,4-BD) was purchased from Carl
Roth GmbH (Germany). All substances were used
as received.
Figure 7 Evolutions of transepidermal water loss. Figure 9 Evolutions of erythema values.
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The influence of the aqueous components ratio [30],
isocyanate component [31], and influence of stirring
speed [32] were already studied by our team in order to
optimize the structures sizes and stability.
The polyaddition reaction between HMDI and diol-
polyether mixture for the PU structures synthesis follows
the reaction from Figure 10.
Isocyanate and hydroxyl components were used in a 1:1.1
molar ratio in order to reduce the amount of secondary
products (amines) and to ensure an easier washing of
products by using distilled water.
PU structures synthesis procedure was already
described in the literature [12,31] and involves the
following steps:
1. Phases preparation – HMDI in acetone 0.5 mM
solution (organic phase) was heated at 40°C; MEG,
1,4-BD and PEG 200 (1:1:2, molar ratio) in distilled
water 0.5 mM solution (aqueous phase) was mixed
with different emulsifiers and heated at 40°C.
2. The organic phase was injected into the aqueous
phase at 40°C under magnetic stirring (500 rpm).
The stirring was maintained for 4 hours at 40°C inFigure 8 Evolutions of melanin values.order to ensure the maturation of the PU structures
walls, even if the structures were formed in the first
three minutes.
3. Acetone and a part of water were removed by slow
evaporation in the oven, keeping the suspensions as
thin layers (approx. 3 mm) in Petri dishes at 60°C
for 12 hours. Products were purified by three cycles
of centrifugation and dispersion in a mixture of
water-acetone (1:1, v/v) in order to eliminate
possible secondary products or unreacted raw
materials.
The previously described procedure was repeated four
times with different emulsifiers, which were chosen in order
to study their effects on the PU characteristics (samples:
PuS-1 with Cremophor EL, 1.5 ml; PuS-2 with Cremophor
A6, 0.2 g; PuS-3 with Cremophor A25, 0.2 g; PuS-4 with
Cremophor RH40, 0.2 g). The samples were carefully dried
and the pH of PU aqueous solutions was measured at the
same concentration.
Physical and chemical characterization
The shape and morphology of the final PU structures were
examined with a Hitachi 2400S SEM as already described
in the literature [33].
Thermal analysis was carried out using a Mettler-Toledo
821e instrument between 30-300°C because most of theFigure 10 Reaction of PU structures synthesis.
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temperature range [34].
Particles size and charge were measured using a Zetasizer
Nano series equipment Nano-Zs, Malvern Instruments.
Samples were diluted in distilled water at a ratio of
1:5000 v/v. The measurements were carried out in dupli-
cate for each sample.
In vitro characterization of similar PU structures was
already done by our team by testing of mesenchymal stem
cells (MSCs) viability. There were obtained good results
after 48 hours based on the Alamar Blue test [31].Animals
Ten CD1Nu/Nu eight weeks old female mice were
purchased from Charles River (Sulzfeld, Germany). The
protocol followed all National Institute of Animal Health
(NIAH) rules: during the experiment animals were
maintained in standard conditions of 12 hours light-dark
cycle, food and water ad libitum, 24±1°C, humidity above
55%. Mice were divided into five equal groups (2 mice for
blank cream and each PU structures type, respectively).Evaluation of skin parameters
PU structures were included in a cream prepared as previ-
ously described in the literature by Pavicic T et al. [35] in
order to observe how they affect skin parameters. The
blank cream used was an oil-in-water emulsion containing
water, hydrogenated polydecene, steareth-2, cetearyl
alcohol, phenoxyethanol, methylparaben, diazolidinyl urea
and disodium EDTA; the other formulations contain the
same ingredients and additionally 0.2% PU structures. The
cream was stretched with a gentle massage till it was totally
absorbed into the back skin every third day (1 ml /
application).
After each application, determination of skin parameters
was performed within 30 minutes. All the measurements
were carried out according to the published guidelines
[36] with a Multiprobe Adapter System (MPA5) from
Courage&Khazaka Electronics, Germany, equipped with a
TewameterWTM300 probe and a MexameterWMX18 probe.
All measurements were done at the same moment of the
day, by the same operator, in a narrow range of temperature
(24±1°C) and air humidity (45±3%).
The nude mice have been used in many studies in
immunology, pathology, genetics, virology, parasitology,
endocrinology, dermatology, radiology and many other
areas [37]. Nude mice are not bald but instead show an
'abortive' reduced hair growth on different sites of the
integument [38]. In this research, CD1Nu/Nu female mice
skin was chosen to study newly synthesized PU structures’
noxiousness; their skin is sensitive to experimentally
induced infections or to other diseases, the lack of hair
being the most significant predisposing factor [39].Skin is the soft outer layer of humans and most animals.
The skin plays a crucial role in protecting the body against
pathogens [40]. Another main role is the function as a
barrier to water permeation, a phenomenon of normal
transfer of water through the stratum corneum into the
atmosphere, known as transepidermal water loss (TEWL),
which represents part of insensible water loss [41]. TEWL
may increase due to disruption of the skin barrier (wounds,
scratches, burns, exposure to solvents or surfactants,
extreme dryness) and is affected by humidity, temperature,
season and moisture content of the skin (hydration level)
[42].
Transepidermal water loss (TEWL) was reported to pre-
dict the irritation potential of a given compound, e.g. a
notable increase of TEWL, meaning a significant reduction
of the skin barrier function, was recorded when sodium
laurylsulfate (SLS) was applied on the skin [43]. In the last
years, TEWL studies focused on the benefits of
phytocompounds used in cosmetology [44] and of the anti-
aging skin products [45]. In this research, the measure-
ments with TewameterWTM300 probe were accomplished
following a procedure previously described in the literature
[46]: the probe was recalibrated in the first day of the trial
according to the manufacturer’s indications [47] while
room humidity and temperature were continuously moni-
tored and kept in a narrow range of values.
Mexametry is an easy, quick and inexpensive technique
used to determine the two components mainly responsible
for the colour of the skin: melanin and haemoglobin
(erythema) [48]. In this study, a MexameterWMX18 probe
with three light-emitting diodes for green, red and infrared
light was used. Instrumental evaluations of skin colour were
performed after each cream application (every third day).
The probe was maintained on the application spot until the
device software displayed the measured values on the
computer screen (1-3 seconds).
All measurements using the Courage&Khazaka MPA5
device were done in triplicate and data were expressed as
mean and standard deviation of the differences between the
current day and the first day of the trial for the same
mouse.
Paired Student’s t tests or One-way Anova followed by
Bonferroni’s post-tests were used to determine the statis-
tical difference between different experimental and blank
groups: *, ** and *** indicate p<0.05, p<0.01 and <0.001.
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